GlassScriptPhysician profile
Charmy B Patel
NPI 1013451921
$1,624.24
in general payments reported to CMS, 2019-2025
15 companies · $555 in 2025
The $555 reported for 2025 was more than what 76% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $271 · 2023: $525 · 2024: $274 · 2025: $555.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,353.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,353.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cequr Corporation | $323.14 | 2022-2025 | Cequr Simplicity |
| Lilly USA, LLC | $269.20 | 2022-2025 | Mounjaro, Jardiance, Zepbound |
| Novo Nordisk INC | $265.72 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Dexcom, INC. | $156.31 | 2023-2025 | Dexcom Stelo Glucose Biosensor, Dexcom G7 Gss (161), Dexcom G6 Transmitter |
| Abbott Laboratories | $104.62 | 2022-2025 | Freestyle Libre 3 |
| Medtronic, INC. | $104.43 | 2022-2025 | Minimed 780g, Inpen Smart Insulin Delivery System |
| Xeris Pharmaceuticals, INC. | $82.55 | 2023 | Gvoke Hypopen |
| Tandem Diabetes Care, INC. | $77.51 | 2022-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Amgen INC. | $54.16 | 2024 | Prolia, Evenity, Tepezza |
| Bayer Healthcare Pharmaceuticals INC. | $50.31 | 2023-2025 | |
| Insulet Corporation | $33.95 | 2025 | Omnipod |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.79 | 2025 | Jardiance |
| Kyowa Kirin, INC. | $27.73 | 2024 | Crysvita |
| Ascendis Pharma Endocrinology INC | $26.52 | 2025 | Yorvipath |
| Sequel Med Tech, LLC | $19.30 | 2025 | Twiist |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charmy Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.